Taking On Challenges And Growing? – Dyne Therapeutics Inc (DYN)

After Hours

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Dyne Therapeutics Inc is $3.87B. A total of 1.34 million shares were traded on the day, compared to an average of 1.21M shares.

In the most recent transaction, HIGH SUSANNA GATTI sold 10,163 shares of DYN for 35.33 per share on Jun 24 ’24. After the transaction, the Chief Operating Officer now owns 148,792 company shares. In a previous transaction on Jun 21 ’24, HIGH SUSANNA GATTI sold 29,787 shares at 35.01 per share. DYN shares that Chief Operating Officer owns now total 148,792.

Among the insiders who sold shares, HIGH SUSANNA GATTI disposed of 40,000 shares on Jun 12 ’24 at a per-share price of $33.36. This resulted in the Chief Operating Officer holding 148,792 shares of DYN after the transaction. In another insider transaction, HIGH SUSANNA GATTI sold 5,270 shares at $31.23 per share on Jun 11 ’24. Company shares held by the Chief Operating Officer now total 148,792.

Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, DYN has a high of $37.22 and a low of $6.40.

Balance Sheet Annually/Quarterly

In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. DYN’s latest balance sheet shows that the firm has $376.57M in Cash & Short Term Investments as of fiscal 2021. There were $32.64M in debt and $28.72M in liabilities at the time. Its Book Value Per Share was $5.49, while its Total Shareholder’s Equity was $368.20M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DYN is Buy with a score of 5.00.

Most Popular

Related Posts